Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

SYDNEY, June 5, 2025 /PRNewswire/ -- Proto Axiom, Australia's leading biotech incubator, and St Vincent's Curran Foundation ...

In a regulatory filing, SPARC said that its partner, Sun Pharmaceutical Industries (SPIL), reported top-line results from ...

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2. All three cohorts show separation from placebo ...

The shares of Sun Pharma Advanced Research Company (SPARC) fell over 18 per cent on Wednesday, on BSE, on the announcement ...

Shares of Sun Pharma Advanced Research Company (SPARC) shares crashed significantly on Wednesday after the company announced ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

STAT6 is a key transcription factor within the IL4/IL13 signaling pathways which act as drivers of inflammation in allergic conditions ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

Allergic March, also known as atopic march, describes the natural progression of allergic diseases, often starting with eczema in infancy and potentially progressing to food allergies, hay fever, and ...

Researchers further explored the relationship between suicidality and skin disease, with a focus on completed suicide among these patients.